logo
Search…
home
TOP News
Latest
RecommendHK StockUS StockChina StockMacroBond
Commercial
GlobalInvestment&FinancingCompany&ProductsCharacterESG
Economy&politics
Hong KongChinaAmerica
Stocks
HK StockChina StockUS Stock
Markets
HK StockUS Stock
IPO
Hong KongAmericaChina
Research
US StockHK Stock
Opinion
Recommendation
home
TOP News
Latest
RecommendHK StockUS StockChina StockMacroBond
Commercial
GlobalInvestment&FinancingCompany&ProductsCharacterESG
Economy&politics
Hong KongChinaAmerica
Stocks
HK StockChina StockUS Stock
Markets
HK StockUS Stock
IPO
Hong KongAmericaChina
Research
US StockHK Stock
Opinion
Recommendation
Search...
search
home
TOP News
Latest
RecommendHK StockUS StockChina StockMacroBond
Commercial
GlobalInvestment&FinancingCompany&ProductsCharacterESG
Economy&politics
Hong KongChinaAmerica
Stocks
HK StockChina StockUS Stock
Markets
HK StockUS Stock
IPO
Hong KongAmericaChina
Research
US StockHK Stock
Opinion
Recommendation
Home > Stocks > HK Stock

On April 27, CHINA RES GAS (01193) spent HKD 10.8736 million to repurchase 579,500 shares.

date
17:43 27/04/2026
avatar
GMT Eight
China Resources Gas (01193) announced that on April 27, 2026, the company spent 10.8736 million Hong Kong dollars to repurchase 57.95 thousand shares.
CHINA RES GAS (01193) announced on April 27, 2026, that the company will spend HK$10.8736 million to repurchase 579,500 shares.
Related Articles
HK Stock
ZHONGYU ENERGY (03633) spent HKD 2.7405 million on April 27 to repurchase 1 million shares.
HK Stock
CITIC (00267): CITIC Offshore Helicopter (000099.SZ) reported a net profit attributable to shareholders of 93.1356 million yuan in the first quarter, an increase of 2.11% year-on-year.
HK Stock
Biocytogen Pharmaceuticals-B (02315) plans to invest 1.6 billion yuan to build an animal center and preclinical CRO service experimental facilities.
ZHONGYU ENERGY (03633) spent HKD 2.7405 million on April 27 to repurchase 1 million shares.
HK Stock
CITIC (00267): CITIC Offshore Helicopter (000099.SZ) reported a net profit attributable to shareholders of 93.1356 million yuan in the first quarter, an increase of 2.11% year-on-year.
HK Stock
Biocytogen Pharmaceuticals-B (02315) plans to invest 1.6 billion yuan to build an animal center and preclinical CRO service experimental facilities.
HK Stock
RECOMMEND
iQIYI’s AI Drama Faces Backlash Over Industry Dynamics
iQIYI’s AI Drama Faces Backlash Over Industry Dynamics
icon
26/04/2026
DeepSeek valuation jumps as Tencent and Alibaba reportedly in talks
DeepSeek valuation jumps as Tencent and Alibaba reportedly in talks
icon
26/04/2026
Intel first proposes intelligent PC concept as digital employee era sees “Lobster” and “Hermes” surge
Intel first proposes intelligent PC concept as digital employee era sees “Lobster” and “Hermes” surge
icon
26/04/2026
logo
Contact US
qr
+852 - 60190728
gmteight@futurecultural.com
Customer Support
About Us
Contact Us
Frequently Asked
Privacy Policy
Terms of Use
Commercial Services
Advertising
Business Development
Copyright
Terms of Service
©️2013 - 2026 GMT EIGHT Holdings. All Rights Reserved.